Bone morphogenetic protein signaling and arthritis

Cytokine and Growth Factor Reviews

Volumn 20, Issue 5-6, 2009, Pages 467-473

  Lories, Rik J U ^a   Luyten, Frank P ^a  

^a Laboratory for Skeletal Development and Joint Disorders   (Belgium)

Author keywords

Ankylosing spondylitis; Bone morphogenetic protein; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; GROWTH DIFFERENTIATION FACTOR 5; OSTEOGENIC PROTEIN 1; RECOMBINANT OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICULAR CARTILAGE; BONE EROSION; CARTILAGE DEGENERATION; CHONDROGENESIS; CHONDROPROTECTION; CHRONIC INFLAMMATION; ENTHESITIS; FRACTURE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOMODULATION; JOINT DESTRUCTION; MECHANICAL STRESS; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; SPINE FUSION; SPONDYLOARTHROPATHY;

ANIMALS; ARTHRITIS; BONE MORPHOGENETIC PROTEINS; CARTILAGE; HUMANS; INFLAMMATION; JOINTS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 70649090101     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2009.10.009     Document Type: Short Survey

References (70)

1. Lories R.J., and Luyten F.P. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 16 3 (2005) 287-298
2. Helmick C.G., Felson D.T., Lawrence R.C., Gabriel S., Hirsch R., Kwoh C.K., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58 1 (2008) 15-25
3. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58 1 (2008) 26-35
4. Klareskog L., Catrina A.I., and Paget S. Rheumatoid arthritis. Lancet 373 9664 (2009) 659-672
5. Braun J., and Sieper J. Ankylosing spondylitis. Lancet 369 9570 (2007) 1379-1390
6. Lories R.J., Luyten F.P., and De Vlam K. Progress in spondylarthritis mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 11 2 (2009) 221
7. Hunter D.J., and Felson D.T. Osteoarthritis. BMJ 332 7542 (2006) 639-642
8. Valdes A.M., and Spector T.D. The contribution of genes to osteoarthritis. Rheum Dis Clin North Am 34 3 (2008) 581-603
9. Feldmann M., and Maini S.R. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223 (2008) 7-19
10. Rubbert-Roth A., and Finckh A. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis Res Ther 11 Suppl. 1 (2009) S1
11. Luyten F.P., Lories R.J., Verschueren P., De Vlam K., and Westhovens R. Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol 20 5 (2006) 829-848
12. Lories R.J., and Luyten F.P. Bone morphogenetic proteins in destructive and remodeling arthritis. Arthritis Res Ther 9 2 (2007) 207
13. Parsonage G., Filer A.D., Haworth O., Nash G.B., Rainger G.E., Salmon M., et al. A stromal address code defined by fibroblasts. Trends Immunol 26 3 (2005) 150-156
14. Urist M.R. Bone: formation by autoinduction. Science 150 698 (1965) 893-899
15. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 4885 (1988) 1528-1534
16. Tsumaki N., and Yoshikawa H. The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 16 3 (2005) 279-285
17. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16 3 (2005) 251-263
18. Fukui N., Ikeda Y., Ohnuki T., Hikita A., Tanaka S., Yamane S., et al. Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 281 37 (2006) 27229-27241
19. Chubinskaya S., Merrihew C., Cs-Szabo G., Mollenhauer J., McCartney J., Rueger D.C., et al. Human articular chondrocytes express osteogenic protein-1. J Histochem Cytochem 48 2 (2000) 239-250
20. Miyamoto Y., Mabuchi A., Shi D., Kubo T., Takatori Y., Saito S., et al. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 39 4 (2007) 529-533
21. Storm E.E., Huynh T.V., Copeland N.G., Jenkins N.A., Kingsley D.M., and Lee S.J. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368 6472 (1994) 639-643
22. Chang S.C., Hoang B., Thomas J.T., Vukicevic S., Luyten F.P., Ryba N.J., et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269 45 (1994) 28227-28234
23. Thomas J.T., Kilpatrick M.W., Lin K., Erlacher L., Lembessis P., Costa T., et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17 1 (1997) 58-64
24. Thomas J.T., Lin K., Nandedkar M., Camargo M., Cervenka J., and Luyten F.P. A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 12 3 (1996) 315-317
25. Southam L., Rodriguez-Lopez J., Wilkins J.M., Pombo-Suarez M., Snelling S., Gomez-Reino J.J., et al. An SNP in the 5′-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum Mol Genet 16 18 (2007) 2226-2232
26. Evangelou E., Chapman K., Meulenbelt I., Karassa F.B., Loughlin J., Carr A., et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 60 6 (2009) 1710-1721
27. Mikic B. Multiple effects of GDF-5 deficiency on skeletal tissues: implications for therapeutic bioengineering. Ann Biomed Eng 32 3 (2004) 466-476
28. Egli R.J., Southam L., Wilkins J.M., Lorenzen I., Pombo-Suarez M., Gonzalez A., et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum 60 7 (2009) 2055-2064
29. Lories R.J., Daans M., Matthys P., Kasran A., Tylzanowski P., Ceuppens J.L., et al. Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum 54 6 (2006) 1736-1746
30. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., and van den Berg W.B. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 6 5 (1998) 306-317
31. Chen P., Vukicevic S., Sampath T.K., and Luyten F.P. Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1. Biochem Biophys Res Commun 197 3 (1993) 1253-1259
32. van Osch G.J., Brittberg M., Dennis J.E., Bastiaansen-Jenniskens Y.M., Erben R.G., Konttinen Y.T., et al. Cartilage repair: past and future-lessons for regenerative medicine. J Cell Mol Med 13 5 (2009) 792-810
33. Kanakaris N.K., Calori G.M., Verdonk R., Burssens P., De Biase P., Capanna R., et al. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury 39 Suppl 2 (2008) S83-S90
34. Vaccaro A.R., Whang P.G., Patel T., Phillips F.M., Anderson D.G., Albert T.J., et al. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 8 3 (2008) 457-465
35. Chubinskaya S., Kumar B., Merrihew C., Heretis K., Rueger D.C., and Kuettner K.E. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 1588 2 (2002) 126-134
36. Loeser R.F., Im H.J., Richardson B., Lu Q., and Chubinskaya S. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage 17 4 (2009) 513-517
37. Iliopoulos D., Malizos K.N., Oikonomou P., and Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE 3 11 (2008) e3740
38. Honsawek S., Chayanupatkul M., Tanavalee A., Sakdinakiattikoon M., Deepaisarnsakul B., Yuktanandana P., et al. Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop (2009)
39. Badlani N., Inoue A., Healey R., Coutts R., and Amiel D. The protective effect of OP-1 on articular cartilage in the development of osteoarthritis. Osteoarthritis Cartilage 16 5 (2008) 600-606
40. Sekiya I., Tang T., Hayashi M., Morito T., Ju Y.J., Mochizuki T., et al. Periodic knee injections of BMP-7 delay cartilage degeneration induced by excessive running in rats. J Orthop Res (2009)
41. Hurtig M., Chubinskaya S., Dickey J., and Rueger D. BMP-7 protects against progression of cartilage degeneration after impact injury. J Orthop Res 27 5 (2009) 602-611
42. Hopwood B., Tsykin A., Findlay D.M., and Fazzalari N.L. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther 9 5 (2007) R100
43. Dell'Accio F., De Bari C., El Tawil N.M., Barone F., Mitsiadis T.A., O'dowd J., et al. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther 8 5 (2006) R139
44. Haag J., and Aigner T. Jun activation domain-binding protein 1 binds Smad5 and inhibits bone morphogenetic protein signaling. Arthritis Rheum 54 12 (2006) 3878-3884
45. Haag J., Chubinskaya S., and Aigner T. Hgs physically interacts with Smad5 and attenuates BMP signaling. Exp Cell Res 312 7 (2006) 1153-1163
46. Haag J., and Aigner T. Identification of calponin 3 as a novel Smad-binding modulator of BMP signaling expressed in cartilage. Exp Cell Res 313 16 (2007) 3386-3394
47. Lories R.J., Derese I., De Bari C., and Luyten F.P. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of Spondyloarthritis. Arthritis Rheum 56 2 (2007) 489-497
48. van der Heijde D., Landewe R., Einstein S., Ory P., Vosse D., Ni L., et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58 5 (2008) 1324-1331
49. Benjamin M., Toumi H., Suzuki D., Hayashi K., and McGonagle D. Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68 6 (2009) 1003-1010
50. Benjamin M., and McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 199 Pt 5 (2001) 503-526
51. McGonagle D., Lories R.J., Tan A., and Benjamin M. The concept of a synovio-entheseal complex and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 56 8 (2007) 2482-2491
52. Lories R.J., Matthys P., Derese I., De Vlam K., and Luyten F.P. Ankylosing enthesitis, dactylitis and onychoperiostitis in a mouse model of psoriatic arthritis. Ann Rheum Dis 63 (2004) 595-598
53. Lories R.J.U., Derese I., and Luyten F.P. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 115 6 (2005) 1571-1579
54. Park M.C., Chung S.J., Park Y.B., and Lee S.K. Suppression of bone morphogenetic proteins attenuates syndesmophytosis by down-regulating smad pathway in aggrecan-induced spondylitis mice. Arthritis Rheum 58 9 (2008) S346
55. van der Kraan P.M., and van Den Berg W.B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 15 3 (2007) 237-244
56. Diarra D., Stolina M., Polzer K., Zwerina J., Ominsky M.S., Dwyer D., et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13 2 (2007) 156-163
57. Itasaki N., and Hoppler S. Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship. Dev Dyn (2009)
58. Lories R.J.U., Derese I., Ceuppens J.L., and Luyten F.P. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48 10 (2003) 2807-2818
59. Sieper J., Appel H., Braun J., and Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 56 3 (2008) 649-656
60. Maksymowych W.P., Chiowchanwisawakit P., Clare T., Pedersen S.J., Ostergaard M., and Lambert R.G. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 60 1 (2009) 93-102
61. Ward M.M., Hendrey M.R., Malley J.D., Learch T.J., Davis Jr. J.C., Reveille J.D., et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 61 7 (2009) 859-866
62. Firestein G.S., Echeverri F., Yeo M., Zvaifler N.J., and Green D.R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94 20 (1997) 10895-10900
63. Strietholt S., Maurer B., Peters M.A., Pap T., and Gay S. Epigenetic modifications in rheumatoid arthritis. Arthritis Res Ther 10 5 (2008) 219
64. Luyten F.P. Mesenchymal stem cells in arthritis. In: Panayi G.S., Firestein G.S., and Wollheim F.A. (Eds). Rheumatoid arthritis: frontiers in pathophysiology and treatment (2005), Oxford University Press, Oxford
65. Daans M., Lories R.J., and Luyten F.P. Dynamic activation of bone morphogenetic protein signaling in collagen induced arthritis supports their role in joint homeostasis and disease. Arthritis Res Ther 10 5 (2008) R115
66. Verschueren P.C., Lories R.J., Daans M., Theate I., Durez P., Westhovens R., et al. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 68 1 (2009) 117-123
67. Marinova-Mutafchieva L., Taylor P., Funa K., Maini R.N., and Zvaifler N.J. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum 43 9 (2000) 2046-2055
68. Marinova-Mutafchieva L., Williams R.O., Funa K., Maini R.N., and Zvaifler N.J. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 46 2 (2002) 507-513
69. Uccelli A., Moretta L., and Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8 9 (2008) 726-736
70. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 52 5 (2005) 1595-1603